Pentraxin 3-a marker of diastolic dysfunction and HF?

Bernhard M. Kaess, Ramachandran S. Vasan

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Inflammation has a pivotal role in cardiac remodeling, and circulating biomarkers of inflammation are independently associated with risk of developing heart failure and with prognosis after onset of the condition. Pentraxin 3 has been suggested as a novel biomarker of left ventricular diastolic dysfunction and heart failure with normal ejection fraction.

Original languageEnglish (US)
Pages (from-to)246-248
Number of pages3
JournalNature Reviews Cardiology
Issue number5
StatePublished - May 2011
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Pentraxin 3-a marker of diastolic dysfunction and HF?'. Together they form a unique fingerprint.

Cite this